NCT04983394 is a NA clinical trial of Virtual Realty Exercises in Covid19, sponsored by Cumhuriyet University.

Who is sponsoring NCT04983394?

NCT04983394 is sponsored by Cumhuriyet University.

What drugs are being tested in NCT04983394?

Interventions in NCT04983394: Virtual Realty Exercises, conventional exercises.

Is NCT04983394 still recruiting?

NCT04983394 is currently completed. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT04983394

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Virtual Reality Exercises on Patients With Post-COVID-19 Condition

Completed NA Last updated 8 September 2025

What this trial tests

NA trial testing Virtual Realty Exercises in Covid19 in 79 participants. Completed in 27 February 2022.

Timeline

30 July 2021

Primary endpoint
27 February 2022

27 February 2022

Quick facts

Lead sponsor	Cumhuriyet University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	79
Start date	30 July 2021
Primary completion	27 February 2022
Estimated completion	27 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Virtual Realty Exercises
conventional exercises

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Cumhuriyet University

Who can join

Adults 18 to 65, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate (I) the effectiveness of motion-controlled video game-based VR exercises on pain, fatigue, functional capacity, mood, and quality of life in patients with PCC, and (II) to determine whether they are superior to conventional exercise.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Motion-Controlled Video Games-Based Virtual Reality Exercise on Patients with Post-COVID-19 Condition: A Randomized Controlled Trial.
Polat M, Oba P, Karadağ A. · · 2025 · PMID 41302301 · DOI 10.3390/healthcare13222914

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Cumhuriyet University trials

Trials by the same sponsor.

NCT07289425 — Effect of a Mobile App for Obese Children on Eating Attitudes, Eating Awareness, and Healthy Eating Self-Efficacy · NA · not yet recruiting
NCT07482735 — Effect of Perturbation Exercise Protocol in Patients With Partial Rotator Cuff Tear: A Single-Blind Randomized Controlle · NA · active not recruiting
NCT07446699 — The Effect of Pushing Techniques Used During Childbirth on Women's Labor Duration, Pain, and Fatigue Levels · NA · active not recruiting
NCT07298681 — The Effect of Benner's Jigsaw Teaching Technique Based on the Novice to Expert Model and Scenario-Based Peripheral Intra · NA · recruiting
NCT07474402 — The Effect of a Multi-Component Breastfeeding Support Program on Breastfeeding Self-Efficacy and Mother-Infant Bonding i · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04983394 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cumhuriyet University
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983394.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing